Hemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamMyron Holubiakand I founded aprivatecompany in2013Not manycompaniesthis size with2 late stageassetsI/ONTAKwas thebest deal Iever madeMino-Lokis our leadassetMino-WrapI'm ashareholdermyselfMino-Lokpotentialmarket>$1BI won't diluteshareholdersThere are noFDAapproveddrugs to treathemorrhoidsInsidersinvested$26.5mI/ONTAKis our leadassetWe will openupinternationalsites forMino-Lok trialWe had aphase 2btrial with100%efficacyOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK'spotentialmarket is>$300mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We intendto submita BLA in2H 2022An actualiMSCupdateWe haveenough cashto go wellinto 2023We willhaveexclusivityHemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamMyron Holubiakand I founded aprivatecompany in2013Not manycompaniesthis size with2 late stageassetsI/ONTAKwas thebest deal Iever madeMino-Lokis our leadassetMino-WrapI'm ashareholdermyselfMino-Lokpotentialmarket>$1BI won't diluteshareholdersThere are noFDAapproveddrugs to treathemorrhoidsInsidersinvested$26.5mI/ONTAKis our leadassetWe will openupinternationalsites forMino-Lok trialWe had aphase 2btrial with100%efficacyOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK'spotentialmarket is>$300mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We intendto submita BLA in2H 2022An actualiMSCupdateWe haveenough cashto go wellinto 2023We willhaveexclusivity

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Hemorrhoids is a $2B market
  2. Only biotech with 2 Myron's on the leadership team
  3. Myron Holubiak and I founded a private company in 2013
  4. Not many companies this size with 2 late stage assets
  5. I/ONTAK was the best deal I ever made
  6. Mino-Lok is our lead asset
  7. Mino-Wrap
  8. I'm a shareholder myself
  9. Mino-Lok potential market >$1B
  10. I won't dilute shareholders
  11. There are no FDA approved drugs to treat hemorrhoids
  12. Insiders invested $26.5m
  13. I/ONTAK is our lead asset
  14. We will open up international sites for Mino-Lok trial
  15. We had a phase 2b trial with 100% efficacy
  16. Our Halo-Lido trial will have final patient by end of 2022
  17. I/ONTAK's potential market is >$300m
  18. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  19. We expect to finish the Mino-Lok trial this year
  20. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  21. We intend to submit a BLA in 2H 2022
  22. An actual iMSC update
  23. We have enough cash to go well into 2023
  24. We will have exclusivity